FDA approved leukemia drugs shows promise in ovarian cancer cells
Links shared publicly online about this topic.
- 1,612total visits
FDA approved leukemia drugs shows promise in ovarian cancer cells
The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found.
View full resource at physorg.com
Tags: Cancer, Leukemia, Leukemia Medication, Ovarian Cancer, Drug, Women's Health, FDA
Most Recently Shared on November 10, 2009 at 6:31 pm By:
FDA approved leukemia drugs shows promise in ovarian cancer cells http://bit.ly/3mTI6Q
FDA Approved Leukemia Drugs Shows Promise In Ovarian Cancer Cells
feeds.sciencedaily.com — “The drug Sprycel, approved for use by the US Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a new study has found.” View full resource at feeds.sciencedaily.com
Most Recently Shared on November 10, 2009 at 11:14 pm By:
FDA Approved Leukemia Drugs Shows Promise In Ovarian Cancer Cells: The drug Sprycel, approved for use by the US Food... http://bit.ly/245ctQ
Advertisement
